Market Research Logo

Cerebro Spinal Fluid (CSF) Management - Medical Devices Pipeline Assessment, 2018

Cerebro Spinal Fluid (CSF) Management - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Cerebro Spinal Fluid (CSF) Management - Medical Devices Pipeline Assessment, 2018 provides an overview of Cerebro Spinal Fluid (CSF) Management currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cerebro Spinal Fluid (CSF) Management pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cerebro Spinal Fluid (CSF) Management under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cerebro Spinal Fluid (CSF) Management and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cerebro Spinal Fluid (CSF) Management under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Cerebro Spinal Fluid (CSF) Management Overview
3 Products under Development
3.1 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Stage of Development
3.2 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Segment
3.3 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Territory
3.4 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Regulatory Path
3.5 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Estimated Approval Date
3.6 Cerebro Spinal Fluid (CSF) Management - Ongoing Clinical Trials
4 Cerebro Spinal Fluid (CSF) Management - Pipeline Products under Development by Companies
4.1 Cerebro Spinal Fluid (CSF) Management Companies - Pipeline Products by Stage of Development
4.2 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Stage of Development
5 Cerebro Spinal Fluid (CSF) Management Companies and Product Overview
5.1 Alcyone Lifesciences Inc Company Overview
5.1.1 Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Arkis BioSciences Company Overview
5.2.1 Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview
5.3 Beckersmith Medical, Inc. Company Overview
5.3.1 Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Biosan Medical Ltd. Company Overview
5.4.1 Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.5 CereVasc LLC Company Overview
5.5.1 CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 Collagen Matrix Inc Company Overview
5.6.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Georgia Institute of Technology Company Overview
5.7.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.8 H-Cubed Inc. Company Overview
5.8.1 H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Integra LifeSciences Holdings Corp Company Overview
5.9.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 InVivo Therapeutics Corp Company Overview
5.10.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.11 Johns Hopkins University Company Overview
5.11.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Kerecis ehf Company Overview
5.12.1 Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview
5.13 Kuros Biosciences AG Company Overview
5.13.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
5.14 Leucadia Therapeutics Company Overview
5.14.1 Leucadia Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
5.15 Microbot Medical Ltd Company Overview
5.15.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Monitor Med Solutions Company Overview
5.16.1 Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview
5.17 Nanonerve Inc. Company Overview
5.17.1 Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.18 NeuraMedica, LLC Company Overview
5.18.1 NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.19 NexGen Medical Systems Inc Company Overview
5.19.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Nurami Medical Ltd Company Overview
5.20.1 Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.21 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.21.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.22 System Science Inc. Company Overview
5.22.1 System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.23 University Hospital Zurich Company Overview
5.23.1 University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview
5.24 University of Iowa Company Overview
5.24.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
5.25 University of Rochester Company Overview
5.25.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.26 University of South Florida Company Overview
5.26.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.27 University of Wisconsin Madison Company Overview
5.27.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
5.28 Vivonics, Inc. Company Overview
5.28.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.29 Wayne State University Company Overview
5.29.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview
6 Cerebro Spinal Fluid (CSF) Management- Recent Developments
6.1 May 09, 2018: Microbot Medical Announces Receiving Notice of Allowance for a U.S. Patent covering its Self-Cleaning Shunt (SCS) Device
6.2 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.3 May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility
6.4 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
6.5 Apr 24, 2018: Arkis BioSciences Brings Endexo Technology To Neurosurgical Use With Its New CerebroFlo EVD Catheter
6.6 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management
6.7 Apr 12, 2018: Microbot Medical’s Self-Cleaning Shunt Awarded a Grant by the European Commission
6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.9 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros
6.10 Feb 27, 2018: Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results
6.11 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017
6.12 Feb 20, 2018: Alcyone Lifesciences Completes Spin-Off of Hydrocephalus Business, Anuncia
6.13 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program
6.14 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.15 Jan 08, 2018: Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Result
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Stage of Development
Table 2: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Segment
Table 3: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Territory
Table 4: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Regulatory Path
Table 5: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Estimated Approval Date
Table 6: Cerebro Spinal Fluid (CSF) Management - Ongoing Clinical Trials
Table 7: Cerebro Spinal Fluid (CSF) Management Companies - Pipeline Products by Stage of Development
Table 8: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Stage of Development
Table 9: Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Alivio Ventricular System - Product Status
Table 11: Alivio Ventricular System - Product Description
Table 12: Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Arkis AutoShunt - Product Status
Table 14: Arkis AutoShunt - Product Description
Table 15: Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 16: FlowSafe - Product Status
Table 17: FlowSafe - Product Description
Table 18: Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Ventritek105 - Product Status
Table 20: Ventritek105 - Product Description
Table 21: CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 22: eShunt - Product Status
Table 23: eShunt - Product Description
Table 24: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: DuraMatrix - Product Status
Table 26: DuraMatrix - Product Description
Table 27: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Hydrocephalus Shunt - Product Status
Table 29: Hydrocephalus Shunt - Product Description
Table 30: H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Ambulatory System For Hydrocephalus Shunt - Product Status
Table 32: Ambulatory System For Hydrocephalus Shunt - Product Description
Table 33: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Certas Plus Tool Kit - Product Status
Table 35: Certas Plus Tool Kit - Product Description
Table 36: Generator - Cerebro Spinal Fluid (CSF) Management - Product Status
Table 37: Generator - Cerebro Spinal Fluid (CSF) Management - Product Description
Table 38: Generator CertaPlus - Product Status
Table 39: Generator CertaPlus - Product Description
Table 40: Hydrocephalic Shunt - Product Status
Table 41: Hydrocephalic Shunt - Product Description
Table 42: Next Generation DuraSeal - Product Status
Table 43: Next Generation DuraSeal - Product Description
Table 44: Ventricular Drainage Device - Product Status
Table 45: Ventricular Drainage Device - Product Description
Table 46: InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Dural Graft - Product Status
Table 48: Dural Graft - Product Description
Table 49: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 50: CADENCE Balloon Shunt - Product Status
Table 51: CADENCE Balloon Shunt - Product Description
Table 52: Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Kerecis Omega3 Dura - Product Status
Table 54: Kerecis Omega3 Dura - Product Description
Table 55: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Neuroseal - Cranial - Product Status
Table 57: Neuroseal - Cranial - Product Description
Table 58: Neuroseal - Spinal - Product Status
Table 59: Neuroseal - Spinal - Product Description
Table 60: Leucadia Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Arethusta - Product Status
Table 62: Arethusta - Product Description
Table 63: Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Self-Cleaning Shunt (SCS) Device - Product Status
Table 65: Self-Cleaning Shunt (SCS) Device - Product Description
Table 66: Microbot Medical Ltd - Ongoing Clinical Trials Overview
Table 67: Self-Cleaning Shunt (SCS) Device - Clinical Investigation of Self-Cleaning Shunt (SCS) Device
Table 68: Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Hydrocephalus Shunt System - Product Status
Table 70: Hydrocephalus Shunt System - Product Description
Table 71: Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Nanofibrous Dural Substitute - Product Status
Table 73: Nanofibrous Dural Substitute - Product Description
Table 74: NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Dural Clip - Product Status
Table 76: Dural Clip - Product Description
Table 77: NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 78: EViTAR FLOWMETER - Product Status
Table 79: EViTAR FLOWMETER - Product Description
Table 80: Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Artifascia - Product Status
Table 82: Artifascia - Product Description
Table 83: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Bovine Pericardium - Dura Substitute - Product Status
Table 85: Bovine Pericardium - Dura Substitute - Product Description
Table 86: Programmable Hydrocephalus Stent - Product Status
Table 87: Programmable Hydrocephalus Stent - Product Description
Table 88: System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Acute Cerebrospinal Fluid Monitor And Control System - Product Status
Table 90: Acute Cerebrospinal Fluid Monitor And Control System - Product Description
Table 91: Implantable Cerebrospinal Fluid Monitor And Control System - Product Status
Table 92: Implantable Cerebrospinal Fluid Monitor And Control System - Product Description
Table 93: University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview
Table 94: SmartShunt - Product Status
Table 95: SmartShunt - Product Description
Table 96: University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Distal Catheter - Product Status
Table 98: Distal Catheter - Product Description
Table 99: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Catheterless Shunt System - Product Status
Table 101: Catheterless Shunt System - Product Description
Table 102: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Shunt Catheter System With Inline Filter - Product Status
Table 104: Shunt Catheter System With Inline Filter - Product Description
Table 105: Sonic Window Cranioplasty Implant - Product Status
Table 106: Sonic Window Cranioplasty Implant - Product Description
Table 107: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
Table 108: Gravity And Pressure Controlled Valve System - Product Status
Table 109: Gravity And Pressure Controlled Valve System - Product Description
Table 110: Hydrocephalus Stent - Product Status
Table 111: Hydrocephalus Stent - Product Description
Table 112: Medical Shunt - Hydrocephalus - Product Status
Table 113: Medical Shunt - Hydrocephalus - Product Description
Table 114: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Shunt Flowmeter - Product Status
Table 116: Shunt Flowmeter - Product Description
Table 117: Wayne State University Pipeline Products & Ongoing Clinical Trials Overview
Table 118: Programmable Antisiphon Shunt System - Product Status
Table 119: Programmable Antisiphon Shunt System - Product Description
Table 120: Glossary
1.2 List of Figures
Figure 1: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Stage of Development
Figure 2: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Segment
Figure 3: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Territory
Figure 4: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Regulatory Path
Figure 5: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Estimated Approval Date
Figure 6: Cerebro Spinal Fluid (CSF) Management - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report